Replies to post #24439 on Endonovo Therapeutics Inc (ENDV)

[Craig305]

I have not tracked the debt as since they have been pre revenue for so long it was not worth the effort. They have to dilute shares for operational expense.

Now with the future potential revenue stream, it will become more viable to hold them accountable and have less debt and let the revenue support them.